Original Article
Author Details :
Volume : 7, Issue : 1, Year : 2020
Article Page : 153-157
https://doi.org/10.18231/j.ijca.2020.027
Abstract
Introduction: Dexmedetomidine, a potent a2-adrenergic agonist with its sedative, anxiolytic, analgesic
and sympatholytic property ; is an ideal agent for premedication. The intravenous bolus is associated with
bradycardia and hypotension; hence we studied the intramuscular route for hemodynamic stability.
Materials and Methods: Sixty adult patients of ASA physical status I and II, aged between 18-60 years,
posted for ear surgery received intramuscular dexmedetomidine 2.5mg/kg 60 minutes prior to induction
of anesthesia as premedication in recovery room with either injection saline bolus in group D (n=30) or
intravenous fentanyl 1.5 mg/kg group DF (n=30) 2 mines before induction in operation theatre. Standard
induction technique was used. Sedation score and hemodynamic changes during laryngoscopy were
recorded.
Results: During laryngoscopy and intubation, transient rise in Heart Rate and Mean arterial pressure seen
in Group D as compared to Group DF; (p <0> values within 3 minutes of laryngoscopy. No patient suffered from profound sedation at any point of observation.
Conclusion: This study provides evidence that intramuscular dexmedetomidine alone acts as
effective premedication agent with attenuation of stress response; and combination of Intramuscular
dexmedetomidine and intravenous fentanyl not only attenuate but also prevents stress response to
laryngoscopy and tracheal intubation.
Keywords: Ear surgery, Tracheal intubation, Fentanyl, Laryngoscopy, Intramuscular dexmedetomidine.
How to cite : Patel N, Shah A, Pandya M J, A comparative study of intramuscular dexmedetomidine alone and intramuscular dexmedetomidine with intravenous fentanyl on hemodynamic response to laryngoscopy and endotracheal intubation for ear surgery under general anesthesia. Indian J Clin Anaesth 2020;7(1):153-157
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.